Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset

By sjmartinez • March 8, 2024

Channick R, Chin KM, McLaughlin VV, Lammi MR, Zamanian RT, Turricchia S, Ong R, Mitchell L, Kim NH. Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset. Cardiol Ther. 2024 Mar 7. doi: 10.1007/s40119-024-00361-w. Epub ahead of print. PMID: 38451426.

Tags: Connective tissue disease, Macitentan, Mixed connective tissue disease, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, real-world evidence, Scleroderma, systemic lupus erythematosus, systemic sclerosis

Stress Trajectory and Hypertension 2 to 7 Years After Delivery: A nuMoM2b-HHS Study

Nuckols VR, Barone Gibbs B, Brewer BC, Gaffey AE, Greaney JL, Patterson F, Greenland P, Saade GR, Grobman WA, Yee LM, Bairey Merz CN, Chung[...]

Incidence and predictors of postoperative recall of propofol injection pain: a prospective observational cohort pilot study

Bellouni G, Clanet M, Touihri K, Delaporte A, Boulos NM, Kim K, Grogan T, Alexander B, Coeckelenbergh S, Joosten A. Incidence and predictors of postoperative[...]

From Insight to Impact: Advancing Learning Health System Capability Through a System-Wide Quality Improvement Symposium

Dermenchyan A, Seiden DS, Bhayani M, Song A, Venkatesan N, Sharma K, Pandrangi K, Han MA. From Insight to Impact: Advancing Learning Health System Capability[...]